Univariate analysis showed that Beclin 1 expression and EGFR and ALK mutations were associated with lymph node metastasis, TNM stage, tumor differentiation and prognosis, but not with gender, age and smoking status (Table 2, P < 0.05). This evidence concerns the gene BECN1 and metastatic malignant neoplasm in the lymph nodes.